Biphosphonates in Advanced Prostate and Renal Cell Cancer – Current Status and Potential Applications

Publisher： Karger

E-ISSN： 1423-0399|76|2|97-105

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.76, Iss.2, 2006-02, pp. : 97-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Anti-Angiogenic Targeted Therapy in Advanced Renal Cell Carcinoma (RCC):Current Status and Future Prospects

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 2, 2008-05 ,pp. : 97-103

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Applications of Adoptive Natural Killer Cell Immunotherapy for Cancer: Current Status and Future Prospects

By  

Oncology Research and Treatment, Vol. 33, Iss. 7, 2010-06 ,pp. : 389-395

Karger

Access to resources Recommend Favorite

Androgen Deprivation Therapy in Prostate Cancer - Current Status in M1 Patients

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 646-652

Karger

Access to resources Recommend Favorite

Can We Prevent Prostate Cancer? Rationale and Current Status of Prostate Cancer Chemoprevention

By  

Urologia Internationalis, Vol. 74, Iss. 4, 2005-05 ,pp. : 289-297

Karger

Access to resources Recommend Favorite

Recurrent Dedifferentiated Paratesticular Liposarcoma with Synchronous Renal Cell Carcinoma and Prostate Cancer

By  

Current Urology, Vol. 6, Iss. 4, 2013-02 ,pp. : 216-218

Karger

Access to resources Recommend Favorite